Why Is Johnson & Johnson (NYSE:JNJ) Back in the Dividend Spotlight?
Why Is Johnson & Johnson (NYSE:JNJ) Back in the Dividend Spotlight? Kalkine Media
Covered in this story
Analyst targets on Johnson & Johnson
- Bank of America: $265 → $278 by Sep 2027 · Neutral via AOL.com
- Raymond James: $254 → $280 by Aug 2027 · Outperform via Investing.com
- Wells Fargo: $254 → $282 by Aug 2027 · Overweight via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $JNJ yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Johnson & Johnson →Dalsna Finance is currently tracking 43 stories mentioning Johnson & Johnson, the earliest published 11 Jun 2026.
Summary aggregated from Kalkine Media's public RSS feed. The full reporting belongs to Kalkine Media — please read it on their site.